NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy

Journal of the Neurological Sciences

Volumn 275, Issue 1-2, 2008, Pages 148-150

  Kay, Cláudia S K ^a   Scola, Rosana H ^a   Lorenzoni, Paulo J ^a   Jarius, Sven ^b   Arruda, Walter O ^a   Werneck, Lineu C ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Acetylcholine receptor antibody; Aquaporin 4 antibody; Devic syndrome; Myasthenia gravis; Neuromyelitis optica; NMO IgG; Thymectomy

Indexed keywords

ACETYLCHOLINE; AZATHIOPRINE; IMMUNOGLOBULIN G;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; MYASTHENIA GRAVIS; MYELOOPTIC NEUROPATHY; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; SEROLOGY; THYMECTOMY; VISUAL ACUITY;

ADULT; FEMALE; HUMANS; IMMUNOGLOBULIN G; MAGNETIC RESONANCE IMAGING; MYASTHENIA GRAVIS; NEUROMYELITIS OPTICA; THYMECTOMY;

EID: 55649107481     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.06.038     Document Type: Article

References (24)

1. Cunha F.M.B., Scola R.H., and Werneck L.C. Myasthenia gravis: clinical evaluation of 153 patients. Arq Neuropsiquiatr 57 (1999) 457-464
2. Lana-Peixoto M.A. Devic's neuromyelitis optica: a critical review. Arq Neuropsiquiatr 66 (2008) 120-138
3. Isbister C.M., Mackenzie P.J., Anderson D., Wade N.K., and Oger J. Co-occurrence of multiple sclerosis and myasthenia gravis in British Columbia. Mult Scler 9 (2003) 550-553
4. Antoine J.C., Camdessanché J.P., Absi L., Lassablière F., and Féasson L. Devic disease and thymoma with anti-central nervous system and antithymus antibodies. Neurology 62 (2004) 978-980
5. Furukawa Y., Yoshikawa H., Yachie A., and Yamada M. Neuromyelitis optica associated with myasthenia gravis: characteristic phenotype in Japanese population. Eur J Neurol 13 (2006) 655-658
6. Kister I., Gulati S., Boz C., Bergamaschi R., Piccolo G., Oger J., et al. Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy. Arch Neurol 63 (2006) 851-856
7. Gotkine M., Fellig Y., and Abramsky O. Occurrence of CNS demyelinating disease in patients with myasthenia gravis. Neurology 67 (2006) 881-883
8. Gotkine M., and Abramsky O. Occurrence of CNS demyelinating disease in patients with myasthenia gravis. Neurology 68 (2007) 1327
9. Nakamura M., Nakashima I., Sato S., Miyazawa I., Fujihara K., and Itoyama Y. Clinical and laboratorial features of neuromyelitis optica with oligoclonal IgG bands. Mult Scler 13 (2007) 332-335
10. Ikeda K., Araki Y., and Iwasaki Y. Occurrence of CNS demyelinating disease in patients with myasthenia gravis. Neurology 68 (2007) 1326
11. Bichuetti D.B., Barros T.M., Oliveira E.M.L., Annes M., and Gabbai A.A. Demyelinating disease in patients with myasthenia gravis. Arq Neuropsiquiatr 66 (2008) 5-7
12. Jarius S., Franciotta D., Bergamaschi R., Wright H., Littleton E., Palace J., et al. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 68 (2007) 1076-1077
13. Wingerchuk D.M., Lennon V.A., Pittock S.J., Lucchinett C.F., and Weinshenker B.G. Revised diagnostic criteria for neuromyelitis optica. Neurology 66 (2006) 1485-1489
14. Domingues R.B., Kuster G.W., Lanes F., and Callegaro D. Recurrent neuromyelitis optica with diffuse central nervous system involvement. Arq Neuropsiquiatr 62 (2004) 543-546
15. Pittock S.J., Lennon V.A., Krecke K., Wingerchuk D.M., Lucchinetti C.F., and Weinshenker B.G. Brain abnormalities in neuromyelitis optica. Arch Neurol 63 (2006) 390-396
16. Vendrame M., and Azizi S.A. The spectrum of neuromyelitis optica: a case of NMO with extensive brain stem involvement. Neurol Res 29 (2007) 32-35
17. Bichuetti D.B., Rivero R.L.M., Oliveira D.M., Souza N.A., Abdala N., Oliveira E.M.L., et al. Neuromyelitis optica: brain abnormalities in a Brazilian cohort. Arq Neuropsiquiatr 66 (2008) 1-4
18. Thorlacius S., Aarli J.A., Riise T., Matre R., and Johnsen H.J. Associated disorders in myasthenia gravis: autoimmune diseases and their relation to thymectomy. Acta Neurol Scand 80 (1989) 290-295
19. Lennon V.A., Wingerchuk D.M., Kryzer T.J., Pittock S.J., Lucchinetti C.F., Fujihara K., et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364 (2004) 2106-2112
20. Lennon V.A., Kryzer T.J., Pittock S.J., Verkman A.S., and Hinson S.R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202 (2005) 473-474
21. Jarius S., Paul F., Franciotta D., Waters P., Zipp F., Hohlfeld R., et al. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 4 (2008) 202-214
22. Vernant J.C., Cabre P., Smadja D., Merle H., Caubarrère I., Mikol J., et al. Recurrent optic neuromyelitis with endocrinopathies: a new syndrome. Neurology 45 (1997) 58-64
23. Pittock S.J., Weinshenker B.G., Lucchinetti C.F., Wingerchuk D.M., Corboy J.R., and Lennon V.A. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 63 (2006) 964-968
24. Song F., Guan Z., Gienapp I.E., Shawler T., Benson J., and Whitacre C.C. The thymus plays a role in oral tolerance in experimental autoimmune encephalomyelitis. J Immunol 177 (2006) 1500-1509